Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Dma1 prevents mitotic exit and cytokinesis by inhibiting the septation initiation network (SIN).

Developmental cell | Dec 13, 2002

http://www.ncbi.nlm.nih.gov/pubmed/12479804

In the fission yeast Schizosaccharomyces pombe, the septation initiation network (SIN) triggers cytokinesis after mitosis. We investigated the relationship between Dma1p, a spindle checkpoint protein and cytokinesis inhibitor, and the SIN. Deletion of dma1 inactivates the spindle checkpoint and allows precocious SIN activation, while overexpressing Dma1p reduces SIN signaling. Dma1p seems to function by inhibiting the SIN activator, Plo1p kinase, since dma1 overexpression and deletion phenotypes suggest that Dma1p antagonizes Plo1p localization. Furthermore, failure to maintain high cyclin-dependent kinase (CDK) activity during spindle checkpoint activation in dma1 deletion cells requires Plo1p. Dma1p itself localizes to spindle pole bodies through interaction with Sid4p. Our observations suggest that Dma1p functions to prevent mitotic exit and cytokinesis during spindle checkpoint arrest by inhibiting SIN signaling.

Pubmed ID: 12479804 RIS Download

Mesh terms: Cell Cycle Proteins | Cell Division | Drosophila Proteins | Genes, cdc | Microtubule-Associated Proteins | Microtubules | Mitosis | Models, Biological | Mutation | Protein Structure, Tertiary | Protein-Serine-Threonine Kinases | Schizosaccharomyces | Schizosaccharomyces pombe Proteins | Signal Transduction | Spindle Apparatus

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, Id: GM58406

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.